CClinicalTrials.gg
CompletedNCT02728791CONDUCTUpdated Jun 25, 2026

Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary Thermodilution

An observational study in Shock and Cardiac Output, Low, sponsored by University Hospital, Brest. Completed at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by University Hospital, Brest · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
42
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Correlation study between the data provided by two measurement systems, trans- pulmonary thermodilution and ClearSight © (non invasive), to determine the interest in routine use (cardiac output, cardiac index, stroke volume and blood pressure).

Read the detailed description

Since 2014, Edwards society has developed a completely non-invasive monitoring device for measurement of blood pressure and continuous cardiac output without inserting foreign intravascular bodies in the patient. Initially tested on healthy volunteers cardiac disease -free, the correlation with the other devices seems to be good. If this ClearSight © system show a relevant accuracy in measuring blood pressure and cardiac output with a specific ICU hospitalized population, it could justify its place in the therapeutic arsenal of monitoring in intensive care.

This is a common care ,prospective observational single center study , concerning the results of blood pressure , cardiac output values and their variations.

02

Conditions studied

  • Shock
  • Cardiac Output, Low
03

In context

Shock

916 studies on the registry are indexed under Shock; 176 are open to participants now.

This study's enrollment of 42 is below the median of 91 across 346 observational studies indexed under Shock.

Browse Shock studies →

Lead sponsor

University Hospital, Brest is the lead sponsor of 594 studies on the registry; 135 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults patients hospitalized in ICU with hemodynamic failure requiring vasoactive drugs

Inclusion criteria

  • age>18
  • hospitalized in surgical ICU, with hemodynamic instability or vaso-active drugs
  • No opposition formulated

Exclusion criteria

Exclusion Criteria:

  • Impossibility of establishment of one of the cardiac output measurement devices
  • Pregnant woman
  • Refuse to participate
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
42 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Comparison of values and changes in cardiac index between the two devices

    Time frame: 2 days

Secondary outcomes

  1. Comparison of values and variations in mean arterial pressure between the two devices

    Time frame: 2 days

  2. Comparison of values and variations in mean cardiac output between the two devices

    Time frame: 2 days

  3. Comparison of values and variations in mean stroke volume variation between the two devices

    Time frame: 2 days

07

Study locations

1 site
  • CHRU BREST, Hôpital de la Cavale Blanche
    Brest, 29200, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02728791
Lead sponsor
University Hospital, Brest
Responsible party
Sponsor
First posted
Apr 5, 2016
Start date
May 10, 2016
Primary completion
Jul 25, 2018
Completion
Jul 25, 2018
Last update
Jun 25, 2026

Study contacts

Olivier HUET
principal investigator · CHU de Brest

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion